These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 23142240

  • 41. The effect of left ventricular systolic function on long term survival in mitral and aortic regurgitation.
    Michel PL, Iung B, Abou Jaoude S, Cormier B, Porte JM, Vahanian A, Acar J.
    J Heart Valve Dis; 1995 Oct; 4 Suppl 2():S160-8; discussion S168-9. PubMed ID: 8563993
    [Abstract] [Full Text] [Related]

  • 42. Attenuation of cardiac dysfunction by a PPAR-alpha agonist is associated with down-regulation of redox-regulated transcription factors.
    Ichihara S, Obata K, Yamada Y, Nagata K, Noda A, Ichihara G, Yamada A, Kato T, Izawa H, Murohara T, Yokota M.
    J Mol Cell Cardiol; 2006 Aug; 41(2):318-29. PubMed ID: 16806263
    [Abstract] [Full Text] [Related]

  • 43. Different functional recovery of the left ventricle after valve replacement for aortic regurgitation: correlation between grade of ventricular arrhythmia and long-term mortality.
    Noji S, Kitamura M, Hachida M, Endo M, Hashimoto A, Koyanagi H.
    J Heart Valve Dis; 1995 May; 4(3):254-9. PubMed ID: 7655685
    [Abstract] [Full Text] [Related]

  • 44. Effects of perindopril on left ventricular remodeling and aortic regurgitation in rats assessed by echocardiography.
    Murakami K, Mizushige K, Noma T, Kimura S, Abe Y, Matsuo H.
    Angiology; 2000 Nov; 51(11):943-52. PubMed ID: 11103863
    [Abstract] [Full Text] [Related]

  • 45. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F, Thomas W, Way K, Tzanidis A, Kompa A, Lewis D, Itescu S, Krum H.
    J Am Coll Cardiol; 2004 Oct 19; 44(8):1679-89. PubMed ID: 15489104
    [Abstract] [Full Text] [Related]

  • 46. [Left ventricular function in post-endocarditis aortic insufficiency and aortic-annular ectasia].
    Klipstein A, Hug R, Turina J, Jenni R, Hess OM.
    Schweiz Med Wochenschr; 1995 Aug 08; 125(31-32):1469-76. PubMed ID: 7676236
    [Abstract] [Full Text] [Related]

  • 47. Growth hormone attenuates myocardial fibrosis in rats with chronic pressure overload-induced left ventricular hypertrophy.
    Moreira VO, Pereira CA, Silva MO, Felisbino SL, Cicogna AC, Okoshi K, Aragon FF, Padovani CR, Okoshi MP, Castro AV.
    Clin Exp Pharmacol Physiol; 2009 Mar 08; 36(3):325-30. PubMed ID: 19278522
    [Abstract] [Full Text] [Related]

  • 48. Effects of chronic activation of peroxisome proliferator-activated receptor-alpha or high-fat feeding in a rat infarct model of heart failure.
    Morgan EE, Rennison JH, Young ME, McElfresh TA, Kung TA, Tserng KY, Hoit BD, Stanley WC, Chandler MP.
    Am J Physiol Heart Circ Physiol; 2006 May 08; 290(5):H1899-904. PubMed ID: 16339830
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Sex differences in the response to angiotensin II receptor blockade in a rat model of eccentric cardiac hypertrophy.
    Walsh-Wilkinson É, Drolet MC, Le Houillier C, Roy ÈM, Arsenault M, Couet J.
    PeerJ; 2019 May 08; 7():e7461. PubMed ID: 31404429
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Are vasodilators still indicated in the treatment of severe aortic regurgitation?
    Inamo J, Enriquez-Sarano M.
    Curr Cardiol Rep; 2007 Apr 08; 9(2):87-92. PubMed ID: 17430674
    [Abstract] [Full Text] [Related]

  • 53. Modulation of fatty acid metabolism is involved in the alleviation of isoproterenol-induced rat heart failure by fenofibrate.
    Li P, Luo S, Pan C, Cheng X.
    Mol Med Rep; 2015 Dec 08; 12(6):7899-906. PubMed ID: 26497978
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Effects of spironolactone treatment on an experimental model of chronic aortic valve regurgitation.
    Zendaoui A, Lachance D, Roussel E, Couet J, Arsenault M.
    J Heart Valve Dis; 2012 Jul 08; 21(4):478-86. PubMed ID: 22953675
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Blockade of the acute activation of mTOR complex 1 decreases hypertrophy development in rats with severe aortic valve regurgitation.
    Drolet MC, Desbiens-Brassard V, Roussel E, Tu V, Couet J, Arsenault M.
    Springerplus; 2015 Jul 08; 4():435. PubMed ID: 26306297
    [Abstract] [Full Text] [Related]

  • 59. Fenofibrate reduces cardiac remodeling by mitochondrial dynamics preservation in a renovascular model of cardiac hypertrophy.
    Castiglioni L, Gelosa P, Muluhie M, Mercuriali B, Rzemieniec J, Gotti M, Fiordaliso F, Busca G, Sironi L.
    Eur J Pharmacol; 2024 Sep 05; 978():176767. PubMed ID: 38909934
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.